GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SkinBioTherapeutics PLC (LSE:SBTX) » Definitions » Current Accrued Expense

SkinBioTherapeutics (LSE:SBTX) Current Accrued Expense : £0.00 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is SkinBioTherapeutics Current Accrued Expense?

SkinBioTherapeutics's Current Accrued Expense for the quarter that ended in Dec. 2023 was £0.00 Mil.


SkinBioTherapeutics Current Accrued Expense Historical Data

The historical data trend for SkinBioTherapeutics's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SkinBioTherapeutics Current Accrued Expense Chart

SkinBioTherapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Current Accrued Expense
Get a 7-Day Free Trial - - - - -

SkinBioTherapeutics Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

SkinBioTherapeutics Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


SkinBioTherapeutics Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of SkinBioTherapeutics's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


SkinBioTherapeutics (LSE:SBTX) Business Description

Traded in Other Exchanges
N/A
Address
Bath Lane, The Core, Newcastle Helix, Newcastle upon Tyne, GBR, NE4 5TF
SkinBioTherapeutics PLC is a life science company focused on skin health. It is focused on the development of technology to protect, manage, and restore skin utilizing proteins found in the human microbiota. It is targeting three specific skin healthcare sectors; cosmetics, infection control, and eczema.

SkinBioTherapeutics (LSE:SBTX) Headlines

From GuruFocus

Silverback Therapeutics and ARS Pharmaceuticals Announce Merger

By Business Wire Business Wire 07-21-2022

ARS Pharmaceuticals Closes Merger with Silverback Therapeutics

By Value_Insider Value_Insider 11-08-2022